期刊文献+

黄体期用药治疗复发性外阴阴道念珠菌病的临床研究

Luteal phase medication treatment of recurrent vulvovaginal candidiasis in clinical research
下载PDF
导出
摘要 目的:探讨在复发性外阴阴道念珠菌病(RVVC)巩固治疗阶段中的合理、有效的治疗方案。方法:将2009年10月至2011年3月在我院妇科门诊确诊为RVVC的患者186例,随机分成2组。在强化治疗后转入巩固治疗中,治疗组选择黄体期(下次月经前1周)口服氟康唑150mg,每3天1次,连用2次/月,共用6个月。对照组不择期口服氟康唑150mg,每周1次,共用6个月。结果:治疗组总有效率95%,对照组总有效率83%,疗效有显著性差异(P<0.05)。结论:黄体期用药治疗复发性外阴阴道念珠菌病(RVVC)能有效的提高治愈率,降低复发率。 Objective:To investigate recurrent vulvovaginal candidiasis(RVVC) consolidation therapy phase of the rational and effective treatment.Methods:from October 2009 to March 2011 in our hospital gynecology clinic patients diagnosed RVVC 186 patients were randomly divided into 2 groups.Transferred to the intensive therapy after consolidation therapy in the treatment group,select the luteal phase(1 week before the next menstruation) oral fluconazole 150mg,every three days,once every 2 times /month,sharing six months.Control group was not selective oral fluconazole 150mg,once a week,sharing six months.Results:The total efficiency of 95% in the control group,the total efficiency of 83%,a significant difference in efficacy(P0.05).Conclusions:Luteal phase treatment of recurrent vulvovaginal candidiasis(RVVC) can effectively improve the cure rate and reduce the relapse rate.
作者 吴雪娟
出处 《求医问药(下半月刊)》 2011年第10期506-507,共2页 Seek Medical and Ask The Medicine
关键词 复发性外阴阴道念珠菌病 氟康唑 黄体期 recurrent vulvovaginal candidiasis fluconazole luteal phase
  • 相关文献

参考文献6

二级参考文献13

  • 1姚冬梅,濮德敏.复发性外阴阴道念珠菌病危险因素分析[J].中国优生与遗传杂志,2007,15(2):60-61. 被引量:21
  • 2Dan M, Poch F, Levin D. High rate of vaginal infections caused by non-C ,albicans candida species among asymptomatic women [ J]. Med Myeol,2002, 40(4) : 383 -386. 被引量:1
  • 3Sobel JD, Zervos M, Reed BD, et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated candida vaginitis: clinical implications [J]. Antimicmb Agents Chemother, 2003, 47(1) :34 -38. 被引量:1
  • 4Edwards SK. European guideline for the management of balanoposthitis [J]. Int J STD AIDS, 2001, 12 (Suppl 3) :68 -72. 被引量:1
  • 5Fratti RA,Ghannoum MA,Edwards JE Jr,et al.Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis.Infect Immun,1996,64:4714-4718. 被引量:1
  • 6Clift RA.Candidiasis in the transplant patient.Am J Med,1984,77:34-38. 被引量:1
  • 7Nawrot U,Grzybek-Hryncewicz K,Zielska U,et al.The study of cell-mediated immune response in recurrent vulvovaginal candidiasis.FEMS Immunol Med Microbiol,2000,29:89-94. 被引量:1
  • 8Polonelli L,De Bernadis F,Conti S,et al.Human natural yeast killer toxin-like cadidicidal antibodies.J Immunol,1996,156:1880-1885. 被引量:1
  • 9Fidel PL Jr,Luo W,Chabain J,et al.Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery.Infect Immun,1997,65:3939-3943. 被引量:1
  • 10Cassone A,Boccanera M,Adriani D,et al.Rats clearing a vaginal infection by Candida albicans acquire specific,antibody-mediated resistance to vaginal infection.Infect Immun,1995,63:2619-2624. 被引量:1

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部